{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:15:03Z","timestamp":1790864103347,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T00:00:00Z","timestamp":1079568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T00:00:00Z","timestamp":1079568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/ar1170","type":"journal-article","created":{"date-parts":[[2004,4,8]],"date-time":"2004-04-08T06:22:24Z","timestamp":1081405344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development"],"prefix":"10.1186","volume":"6","author":[{"given":"James F","family":"Fries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eswar","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,18]]},"reference":[{"key":"1159_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/1467-8519.00160","volume":"13","author":"R Ashcroft","year":"1999","unstructured":"Ashcroft R: Equipoise, knowledge and ethics in clinical research and practice. Bioethics. 1999, 13: 314-326. 10.1111\/1467-8519.00160.","journal-title":"Bioethics"},{"key":"1159_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM198707163170304","volume":"317","author":"B Freedman","year":"1987","unstructured":"Freedman B: Equipoise and the ethics of clinical research. N Engl J Med. 1987, 317: 141-145.","journal-title":"N Engl J Med"},{"key":"1159_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1126\/science.373117","volume":"204","author":"EF Loftus","year":"1979","unstructured":"Loftus EF, Fries JF: Informed consent may be hazardous to health. Science. 1979, 204: 11-","journal-title":"Science"},{"key":"1159_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jme.17.1.30","volume":"17","author":"N Johnson","year":"1991","unstructured":"Johnson N, Lilford RJ, Brazier W: At what level of collective equipoise does a clinical trial become ethical?. J Med Ethics. 1991, 17: 30-34.","journal-title":"J Med Ethics"},{"key":"1159_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0197-2456(03)00020-5","volume":"24","author":"N Mills","year":"2003","unstructured":"Mills N, Donovon JC, Smith M, Jacoby A, Neal DE, Handy FC: Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the Protect study. Controlled Clin Trials. 2003, 24: 272-282. 10.1016\/S0197-2456(03)00020-5.","journal-title":"Controlled Clin Trials"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(00)02605-2","volume":"356","author":"B Djulbegovic","year":"2000","unstructured":"Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH: The uncertainty principle and industry-sponsored research. Lancet. 2000, 356: 635-638. 10.1016\/S0140-6736(00)02605-2.","journal-title":"Lancet"},{"key":"1159_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1467-8519.1995.tb00306.x","volume":"9","author":"R Gifford","year":"1995","unstructured":"Gifford R: Community-equipoise and the ethics of randomized clinical trials. Bioethics. 1995, 9: 127-148.","journal-title":"Bioethics"},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11912-001-0024-5","volume":"3","author":"B Djulbegovic","year":"2001","unstructured":"Djulbegovic B: Acknowledgement of uncertainty: a fundamental means to ensure scientific and ethical validity in clinical research. Curr Oncol Rep. 2001, 3: 389-395.","journal-title":"Curr Oncol Rep"},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jme.24.6.401","volume":"24","author":"AL Avins","year":"1998","unstructured":"Avins AL: Can unequal be more fair? Ethics, subject allocation, and randomized clinical trials. J Med Ethics. 1998, 24: 401-408.","journal-title":"J Med Ethics"},{"key":"1159_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0277-9536(98)00153-1","volume":"47","author":"JA Chard","year":"1998","unstructured":"Chard JA, Lilford RJ: The use of equipoise in clinical trials. Soc Sci Med. 1998, 47: 891-898. 10.1016\/S0277-9536(98)00153-1.","journal-title":"Soc Sci Med"},{"key":"1159_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S0963180100008136","volume":"6","author":"JH Karlawish","year":"1997","unstructured":"Karlawish JH, Lantos J: Community equipoise and the architecture of clinical research. Camb Q Healthc Ethics. 1997, 6: 385-396.","journal-title":"Camb Q Healthc Ethics"},{"key":"1159_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jme.22.3.135","volume":"22","author":"P Alderson","year":"1996","unstructured":"Alderson P: Equipoise as a means of managing uncertainty: personal, communal and proxy. J Med Ethics. 1996, 22: 135-139.","journal-title":"J Med Ethics"},{"key":"1159_CR13","first-page":"892","volume":"50","author":"G Elwyn","year":"2000","unstructured":"Elwyn G, Edwards A, Kinnersley P, Grol R: Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. Br J Gen Pract. 2000, 50: 892-899.","journal-title":"Br J Gen Pract"},{"key":"1159_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/sim.694","volume":"20","author":"K Chaloner","year":"2001","unstructured":"Chaloner K, Rhame FS: Quantifying and documenting prior beliefs in clinical trials. Stat Med. 2001, 20: 581-600. 10.1002\/sim.694.abs.","journal-title":"Stat Med"},{"key":"1159_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM198209163071204","volume":"307","author":"A Schafer","year":"1982","unstructured":"Schafer A: The ethics of the randomized clinical trial. N Engl J Med. 1982, 307: 719-724.","journal-title":"N Engl J Med"},{"key":"1159_CR16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/1529-0131(200108)44:8<::AID-ART341>3.0.CO;2-4","volume":"44","author":"American College of Rheumatology","year":"2001","unstructured":"American College of Rheumatology: Arthritis and Rheumatism abstract supplement, 2001 Annual Scientific Meeting. Arthritis Rheum. 2001, 44: S1-S400.","journal-title":"Arthritis Rheum"},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/archinte.1994.00420020059007","volume":"154","author":"PA Rochon","year":"1994","unstructured":"Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, Chalmers TC: A study of manufacturer-supported trials of non-steroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994, 154: 157-163. 10.1001\/archinte.154.2.157.","journal-title":"Arch Intern Med"},{"key":"1159_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.289.4.454","volume":"289","author":"JE Bekelman","year":"2003","unstructured":"Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003, 289: 454-465. 10.1001\/jama.289.4.454.","journal-title":"JAMA"},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.290.7.921","volume":"290","author":"B Als-Nielsen","year":"2003","unstructured":"Als-Nielsen B, Chen W, Gluud C, Kjaergard LL: Association of funding and conclusions in randomized drug trials. JAMA. 2003, 290: 921-928. 10.1001\/jama.290.7.921.","journal-title":"JAMA"},{"key":"1159_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/art.10228","volume":"46","author":"JR O'Dell","year":"2002","unstructured":"O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G: Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002, 46: 1164-1170. 10.1002\/art.10228.","journal-title":"Arthritis Rheum"},{"key":"1159_CR21","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0140-6736(01)06891-X","volume":"358","author":"JSG Montaner","year":"2001","unstructured":"Montaner JSG, O'Shaughnessy MV, Schecter MT: Industry-sponsored clinical research: a double-edged sword. Lancet. 2001, 358: 1893-1895. 10.1016\/S0140-6736(01)06891-X.","journal-title":"Lancet"},{"key":"1159_CR22","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1001\/jama.287.21.2825","volume":"287","author":"CM Olson","year":"2002","unstructured":"Olson CM, Rennie D, Cook D, Dickersin K, Flanigan A, Hogan JW, Zhu Q, Reiling J, Pace B: Publication bias in editorial decision making. JAMA. 2002, 287: 2825-2828. 10.1001\/jama.287.21.2825.","journal-title":"JAMA"},{"key":"1159_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jama.1992.03480030052036","volume":"267","author":"K Dickersin","year":"1992","unstructured":"Dickersin K, Min Y, Mienert C: Factors influencing publication of research results. JAMA. 1992, 267: 374-378. 10.1001\/jama.267.3.374.","journal-title":"JAMA"},{"key":"1159_CR24","first-page":"182","volume":"11","author":"NC Abbot","year":"1998","unstructured":"Abbot NC, Erst E: Publication bias: direction of outcome less important than scientific quality. Perfusion. 1998, 11: 182-184.","journal-title":"Perfusion"},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jama.290.4.495","volume":"290","author":"MK Krzyzanowska","year":"2003","unstructured":"Krzyzanowska MK, Pintilie M, Tannock IF: Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003, 290: 495-501. 10.1001\/jama.290.4.495.","journal-title":"JAMA"},{"key":"1159_CR26","volume-title":"The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research","author":"National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research","year":"1978","unstructured":"National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. 1978, DHEW publication no. (OS) 78-0012. Washington, DC: Government Printing Office"},{"key":"1159_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0140-6736(05)60641-1","volume":"351","author":"E Shuster","year":"1998","unstructured":"Shuster E: The Nuremberg code: Hippocratic ethics and human rights. Lancet. 1998, 351: 974-977. 10.1016\/S0140-6736(00)80046-X.","journal-title":"Lancet"},{"key":"1159_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.288.3.358","volume":"288","author":"SD Halpern","year":"2002","unstructured":"Halpern SD, Karlawish JHT, Berlin JA: The continuing unethical conduct of underpowered clinical trials. JAMA. 2002, 288: 358-362. 10.1001\/jama.288.3.358.","journal-title":"JAMA"},{"key":"1159_CR29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/bmj.313.7069.1390","volume":"313","author":"J Savulescu","year":"1996","unstructured":"Savulescu J, Chalmers I, Blunt J: Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ. 1996, 313: 1390-1393.","journal-title":"BMJ"},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/bmj.326.7396.980","volume":"326","author":"RJ Lilford","year":"2003","unstructured":"Lilford RJ: Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise it is anyway?. BMJ. 2003, 326: 980-981. 10.1136\/bmj.326.7396.980.","journal-title":"BMJ"},{"key":"1159_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMsa020349","volume":"347","author":"KA Schulman","year":"2002","unstructured":"Schulman KA, Seils DM, Timbie JW, Sugarman J, Dame LA, Weinfurt KP, Mark DB, Califf RM: A national survey of provisions in clinical trial agreements between medical schools and industry sponsors. N Engl J Med. 2002, 347: 1335-1341. 10.1056\/NEJMsa020349.","journal-title":"N Engl J Med"},{"key":"1159_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jme.26.5.319","volume":"26","author":"T Toroyan","year":"2000","unstructured":"Toroyan T, Roberts I, Oakley A: Randomisation and resource allocation: a missed opportunity for evaluating health care and social interventions. J Med Ethics. 2000, 26: 319-322. 10.1136\/jme.26.5.319.","journal-title":"J Med Ethics"}],"container-title":["Arthritis Res Ther"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar1170\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:06:03Z","timestamp":1714061163000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar1170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,18]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,6]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1186\/ar1170","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,18]]},"assertion":[{"value":"4 February 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R250"}}